Blanket Purchase Agreement EPBPA13D0007

The Department of the Navy Bureau of Medicine and Surgery, Defense Health Agency, and other agencies awarded multiple firm fixed price delivery orders against an indefinite delivery contract held by Gen-Probe Incorporated to procure COVID-19 reagents, assays, and related products. Task orders were issued between July 2020 and January 2022 for places of performance including Marlborough, MA; San Diego, CA; and Portsmouth, VA. Values ranged from $2,300 to $9,663,610 with periods of performance...

Genscript USA Inc. has been awarded a blanket purchase agreement by the United States Department of Agriculture Animal and Plant Health Inspection Service to provide SARS-CoV-2 surrogate virus neutralization test kits and associated reagents. The potential value of the BPA is $1.5 million through August 2024. Under the BPA, Genscript has received multiple firm fixed price call orders from the Department of Agriculture and its sub-agencies Wildlife Services and Marketing and Regulatory Programs...

This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, is for the provision of molecular diagnostic viral testing reagents and supplies. The $452,140.05 BPA call, issued under Roche's General Services Administration (GSA) Critical Analyzers, Laboratory (FSS-66-III) schedule contract, has an ultimate completion date of...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA - VHA VISN 17) awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide GENMARK reagents for diagnostic testing needs. The single award contract has a potential value of $400,000 and a period of performance through July 16, 2028. A firm fixed price delivery order for $63,504 was also issued for one year starting July 17, 2023 for GENMARK reagents to be...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Abbott Molecular Inc. two Blanket Purchase Agreement calls to provide HIV-1 genotyping testing services and associated reagents. Under the first BPA call awarded February 27, 2021 with a completion date of February 26, 2022, Abbott Molecular will deliver ViroSeq reagents for HIV-1 genotyping testing to support clinical care and research programs in Des Plaines, Illinois. This call...

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22) awarded a single-award Blanket Purchase Agreement (BPA) to Biomerieux Inc. for Polymerase Chain Reaction (PCR) diagnostic services. The BPA, valued up to $2,273,824.38, has a base year with two one-year option periods, and will provide PCR testing capabilities to VA healthcare facilities within VISN 22, which covers Southern California and Southern Nevada. Biomerieux Inc., a global leader in in vitro...

This is a Blanket Purchase Agreement (BPA) awarded by the Department of Health and Human Services (HHS) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The BPA has a ceiling value of $10,000,000,000 and a period of performance through June 30, 2024. Under this BPA, Genscript provides a wide range of molecular biology products and services to support biomedical research and public health initiatives across multiple HHS agencies, including the National Institutes of...

The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a single award blanket purchase agreement to Fisher Scientific Company L.L.C. for GENEXUS reagents. The potential value of the agreement is $4,192,985.00 with a period of performance from December 10, 2021 through December 9, 2023. Two task orders have been issued against this agreement. The first task order is valued at $1,132,150.55 for GENEXUS REAGENTS with a period of performance...

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Qiagen, LLC, a division of Qiagen N.V., for the provision of a Polymerase Chain Reaction (PCR) Instrumentation Platform and Supplies (Reagent Rental). The single-award BPA, valued at up to $158,772.00 over its four-year period of performance, enables the VA's Veterans Integrated Service Network 16 to acquire Qiagen's specialized molecular diagnostics products and services to...